Literature DB >> 16184465

Bladder cancer risk in painters: a review of the epidemiological evidence, 1989-2004.

Cristina Bosetti1, Enrico Pira, Carlo La Vecchia.   

Abstract

Epidemiological studies on the potential association between painting and the risk of bladder cancer published after the Monograph of the International Agency for Research on Cancer N. 47 of 1989 have been systematically reviewed. These included four cohort studies on the incidence of bladder cancer among painters, with a pooled relative risk (RR) of 1.10 (95% confidence interval, CI, 1.03-1.18), based on 893 cases observed. The corresponding summary RR from four cohort studies on mortality was 1.23 (95% CI 1.11-1.37), based on 370 deaths. The pooled RR from 14 case-control studies and a pooled-analysis of other 11 case-control studies was 1.35 (95% CI 1.19-1.53), based on 465 cases exposed. Overall, the RR from all epidemiological studies was 1.17 (95% 1.11-1.27). Thus, recent epidemiological evidence indicates a moderate excess risk for bladder cancer in painters. Some studies, however, suggested that any such risk would have been greater for exposures in the distant past. Open issues for interpretation include residual confounding by social class and tobacco smoking, and understanding the time-risk relation. In particular, the potential residual risk related to exposure over the last two to three decades remains to be defined.

Entities:  

Mesh:

Year:  2005        PMID: 16184465     DOI: 10.1007/s10552-005-3636-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  10 in total

1.  Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.

Authors:  Su-Xia Li; Qiang-Sheng Dai; Su-Xiu Chen; Shao-Dan Zhang; Xiao-Yu Liao; Xia Deng; Hong-Bo Chi; Feng-Jie Li; Jin-Hong Zhu; Yi-Yan Jiang
Journal:  Tumour Biol       Date:  2013-12-18

2.  XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis.

Authors:  Fei Zhang; Jian-Hong Wu; Wei Zhao; Hai-Tao Liu
Journal:  Tumour Biol       Date:  2013-05-01

Review 3.  Environmental and occupational causes of cancer: new evidence 2005-2007.

Authors:  Richard W Clapp; Molly M Jacobs; Edward L Loechler
Journal:  Rev Environ Health       Date:  2008 Jan-Mar       Impact factor: 3.458

4.  XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.

Authors:  Zhenqiang Fang; Fanglin Chen; Xiangwei Wang; Shanhong Yi; Wei Chen; Gang Ye
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

Review 5.  Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.

Authors:  Bénédicte Clin; Jean-Claude Pairon
Journal:  BMC Public Health       Date:  2014-11-06       Impact factor: 3.295

6.  Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk.

Authors:  Yi Zhi; Jing Yu; Yang Liu; Quanfang Wei; Fang Yuan; Xiaozhou Zhou; Bo Song; Zhiwen Chen; Jin Yang
Journal:  Int J Med Sci       Date:  2012-08-17       Impact factor: 3.738

7.  Occupational cancer in Britain. Urinary tract cancers: bladder and kidney.

Authors:  Terry Brown; Rebecca Slack; Lesley Rushton
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

Review 8.  The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.

Authors:  Kun Dou; Qingzhu Xu; Xiaolu Han
Journal:  Diagn Pathol       Date:  2013-07-02       Impact factor: 2.644

Review 9.  Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses.

Authors:  Abdulmohsen H Al-Zalabani; Kelly F J Stewart; Anke Wesselius; Annemie M W J Schols; Maurice P Zeegers
Journal:  Eur J Epidemiol       Date:  2016-03-21       Impact factor: 8.082

10.  The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population.

Authors:  Nan Sha; Hao Xu; Tao Chen; Da-Wei Tian; Wan-Qin Xie; Lin-Guo Xie; Yu Zhang; Chen Xing; Xiao-Teng Liu; Zhong-Hua Shen; Zhou-Liang Wu; Hai-Long Hu; Chang-Li Wu
Journal:  Onco Targets Ther       Date:  2016-03-07       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.